207 related articles for article (PubMed ID: 26842910)
21. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression.
Wu Y; Yao Y; Yun Y; Wang M; Zhu R
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31409725
[TBL] [Abstract][Full Text] [Related]
24. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
Huang Q; Wu YY; Xing SJ; Yu ZW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380
[TBL] [Abstract][Full Text] [Related]
25. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
[TBL] [Abstract][Full Text] [Related]
26. [miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].
Li X; Zhao J; Tang J
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):892-6. PubMed ID: 25623761
[TBL] [Abstract][Full Text] [Related]
27. Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).
Zhao L; Wang Y; Jiang L; He M; Bai X; Yu L; Wei M
J Exp Clin Cancer Res; 2022 Mar; 41(1):94. PubMed ID: 35279218
[No Abstract] [Full Text] [Related]
28. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
[TBL] [Abstract][Full Text] [Related]
29. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
Sun H; Sun Y; Chen Q; Xu Z
Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
[TBL] [Abstract][Full Text] [Related]
30. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].
Huang C; Cao P; Xie Z; Zhu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
32. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin.
Han B; Huang J; Han Y; Hao J; Wu X; Song H; Chen X; Shen Q; Dong X; Pang H; Cai L
Int J Biol Macromol; 2019 Mar; 125():544-556. PubMed ID: 30537505
[TBL] [Abstract][Full Text] [Related]
33. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
[TBL] [Abstract][Full Text] [Related]
34. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
[TBL] [Abstract][Full Text] [Related]
35. Co-treatment With Aripiprazole and Vincristine Sensitizes P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells.
Shin JK; Kim HS; Yoon S
Anticancer Res; 2024 Mar; 44(3):1051-1062. PubMed ID: 38423668
[TBL] [Abstract][Full Text] [Related]
36. microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
Zeng H; Wang L; Wang J; Chen T; Li H; Zhang K; Chen J; Zhen S; Tuluhong D; Li J; Wang S
Arch Biochem Biophys; 2018 Aug; 651():52-60. PubMed ID: 29802821
[TBL] [Abstract][Full Text] [Related]
37. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
[TBL] [Abstract][Full Text] [Related]
40. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]